HolderBook

BICARA THERAPEUTICS INC (BCAX)

Institutional ownership reported to the SEC as of Q3 2026, across 9 quarters.

4
Reporting holders
$37.9K
Reported value
0.0%
Calls
0.0%
Puts
-174
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
GAMMA Investing LLC$27.7K1,4910.00%8q+1.8%
Versant Capital Management, Inc$8.1K4340.00%6qHELD
Farther Finance Advisors, LLC$1.5K820.00%5q-57.9%-$2.1K
CoreCap Advisors, LLC$596320.00%5qHELD

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-10-0713G/AT. Rowe Price Investment Management, Inc.4.2%
2026-08-1313G/AJANUS HENDERSON GROUP Ltd.4.8%
2026-07-2713GBlackRock, Inc.5.4%

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-07-08Cohlhepp RyanPresident and COOSold28,214$817.6K ×3
2026-07-08Hyep IvanChief Financial OfficerSold28,000$807.7K ×3
2026-08-10Cohlhepp RyanPresident and COOSold18,750$524.5K
2026-09-08Cohlhepp RyanPresident, COO & Interim CEOSold17,500$400.7K ×2
2026-04-20Mazumdar ClaireChief Executive OfficerSold15,000$354.1K
2026-08-10Hyep IvanChief Financial OfficerSold12,500$349.6K
2026-05-18Mazumdar ClaireChief Executive OfficerSold15,000$300.6K ×2
2026-04-15Cohlhepp RyanPresident and COOSold12,500$287.6K ×2
2026-07-10Mazumdar ClaireChief Executive OfficerSold10,000$284.2K ×2
2026-08-10Mazumdar ClaireChief Executive OfficerSold10,000$279.8K
2026-05-15Cohlhepp RyanPresident and COOSold12,500$253.6K ×2
2026-04-21Hyep IvanChief Financial OfficerSold9,200$211.6K

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20264$37.9K2,0390110.0%
Q2 2026178$2.3B75,964,7434166370.5%
Q1 2026148$1.4B70,858,4872355380.4%
Q4 2025141$1.0B59,238,3574143320.3%
Q3 2025116$790.5M50,241,0752641260.0%
Q2 2025108$475.4M51,172,7683343150.0%
Q1 202593$633.9M48,610,4422824180.0%
Q4 202485$813.6M46,709,070332370.0%
Q3 202469$927.6M36,418,29467000.0%